Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00344ApprovedSmall moleculeAntidepressive Agents Indicated for DepressionAntidepressive Agents, Tricyclic
Protriptyline is a tricyclic antidepressant that is indicated in the treatment of depression only under close clinical supervision. TCAs are structurally similar to phenothiazines.
- Mechanism
- Curator reviewed
Protriptyline acts by decreasing the reuptake of norepinephrine and serotonin (5-HT).
- Primary indication
- For the treatment of depression.Curator reviewed · 1 structured indication
- Formula / weight
- C19H21N · 263.3767 g/mol (avg)
- First approval
- Canada, 1966 · United States, 2000
- Also known as
- Amimetilina
- Code names
- MK-240
Resolves to
Clinical / RWD
Structure
InChIKey
BWPIARFWQZKAIA-UHFFFAOYSA-NSMILESCNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12Targets
Transporters
What you can answer from here — as of September 23, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Protriptyline, and which of those have an active Phase 3 trial?